Centene Corporation
| Company Name | Centene Corporation |
| Stock Symbol | CNC |
| Class Period | December 12, 2024 to June 30, 2025 |
| Lead Plaintiff Motion Deadline | September 08, 2025 |
On July 1, 2025, Centene announced that it was withdrawing its previous 2025 financial guidance following analysis of data from the Affordable Care Act marketplace that showed a significant revenue decline from a risk-sharing mechanism.
On this news, Centene’s stock price fell $22.87, or 40.4%, to close at $33.78 per share on July 2, 2025, thereby injuring investors.
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) a preliminary analysis of over two-thirds of Centene’s marketplace share showed lower-than-anticipated enrollment and increased aggregate market morbidity; and (2) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Submit Your Information
If you suffered a loss on your Centene Corporation investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.